Stonepine Capital Management, LLC Day One Biopharmaceuticals, Inc. Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 235,000 shares of DAWN stock, worth $2.88 Million. This represents 2.4% of its overall portfolio holdings.
Number of Shares
235,000
Previous 205,675
14.26%
Holding current value
$2.88 Million
Previous $2.87 Billion
3.92%
% of portfolio
2.4%
Previous 1.81%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
79.7MCall Options Held
130KPut Options Held
217K-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.8 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$71.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$70.6 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.8 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $901M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...